Immunological correlates of vaccination and infection for equine herpesvirus 1

Clinical and Vaccine Immunology

Volumn 19, Issue 2, 2012, Pages 235-241

  Goodman, Laura B ^a   Wimer, Christine ^a,b   Dubovi, Edward J ^a   Gold, Carvel ^a   Wagner, Bettina ^a  

^a Cornell University ^*  (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; EQUINE HERPES VIRUS VACCINE; GAMMA INTERFERON; HERPES VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN G5; IMMUNOGLOBULIN G6; IMMUNOGLOBULIN G7; INACTIVATED VIRUS VACCINE; LIVE VACCINE; PNEUMABORT; RHINOMUNE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; EPIDEMIC; EQUINE HERPES VIRUS; FEMALE; HERPES ZOSTER; HUMORAL IMMUNITY; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; SURVIVOR; VACCINATION; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, EQUID; HERPESVIRUS 4, EQUID; HERPESVIRUS VACCINES; HORSE DISEASES; HORSES; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; INTERFERON-ALPHA; INTERFERON-GAMMA; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; VACCINATION; VIRAL VACCINES;

EID: 84856493189     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05522-11     Document Type: Article

References (44)

1. Allen G, Yeargan M, Costa LR, Cross R. 1995. Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1. J. Virol. 69:606-612. (Pubitemid 24378849)
2. Allen GP. 2006. Antemortem detection of latent infection with neuropathogenic strains of equine herpesvirus-1 in horses. Am. J. Vet. Res. 67:1401-1405. (Pubitemid 44275496)
3. Allen GP, et al. 1999. Advances in understanding of the pathogenesis, epidemiology and immunological control of equine herpesvirus abortion, p. 129-146. In Nakajima H, Plowright W (ed.), Equine infectious diseases VIII: proceedings of the Eighth International Conference. R&W Publishers, Newmarket, United Kingdom.
4. Breathnach CC, Soboll G, Suresh M, Lunn DP. 2005. Equine herpesvirus-1 infection induces IFN-gamma production by equine T lymphocyte subsets. Vet. Immunol. Immunopathol. 103:207-215. (Pubitemid 40038207)
5. Breathnach CC, Yeargan MR, Sheoran AS, Allen GP. 2001. The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens. Equine Vet. J. 33:651-657. (Pubitemid 33640023)
6. Carvalho R, Oliveira AM, Souza AM, Passos LM, Martins AS. 2000. Prevalence of equine herpesvirus type 1 latency detected by polymerase chain reaction. Arch. Virol. 145:1773-1787.
7. Doll ER, Bryans JT. 1962. Development of complement-fixing and virus-neutralizing antibodies in viral rhinopneumonitis of horses. Am. J. Vet. Res. 23:843-846.
8. Edington N, Bridges CG, Huckle A. 1985. Experimental reactivation of equid herpesvirus 1 (EHV 1) following the administration of corticosteroids. Equine Vet. J. 17:369-372.
9. Edington N, Bridges CG, Patel JR. 1986. Endothelial cell infection and thrombosis in paralysis caused by equid herpesvirus-1: equine stroke. Arch. Virol. 90:111-124.
10. Fields BN, Knipe DM, Howley PM. 2007. Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
11. Goehring LS, van Winden SC, van Maanen C, Sloet van Oldruitenborgh- Oosterbaan MM. 2006. Equine herpesvirus type 1-associated myeloencephalopathy in The Netherlands: a four-year retrospective study (1999-2003). J. Vet. Intern. Med. 20:601-607. (Pubitemid 43774107)
12. Goehring LS, et al. 2010. Control of EHV-1 viremia and nasal shedding by commercial vaccines. Vaccine 28:5203-5211.
13. Goodman LB, et al. 2006. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1). Vaccine 24:3636-3645.
14. Hannant D, et al. 1993. Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain. Res. Vet. Sci. 54:299-305. (Pubitemid 23171881)
15. Hartley CA, Wilks CR, Studdert MJ, Gilkerson JR. 2005. Comparison of antibody detection assays for the diagnosis of equine herpesvirus 1 and 4 infections in horses. Am. J. Vet. Res. 66:921-928. (Pubitemid 40812690)
16. Hayward AR, Herberger M. 1987. Lymphocyte responses to varicella zoster virus in the elderly. J. Clin. Immunol. 7:174-178. (Pubitemid 17049976)
17. Heldens JG, et al. 2001. Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares. Vaccine 19:4307-4317. (Pubitemid 32703653)
18. Henninger RW, et al. 2007. Outbreak of neurologic disease caused by equine herpesvirus-1 at a university equestrian center. J. Vet. Intern. Med. 21:157-165.
19. Hubert PH, Birkenmaier S, Rziha HJ, Osterrieder N. 1996. Alterations in the equine herpesvirus type-1 (EHV-1) strain RacH during attenuation. Zentralbl. Veterinarmed. B 43:1-14. (Pubitemid 126469320)
20. Ito T, Wang YH, Liu YJ. 2005. Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9. Springer Semin. Immunopathol. 26:221-229.
21. Kydd JH, Smith KC, Hannant D, Livesay GJ, Mumford JA. 1994. Distribution of equid herpesvirus-1 (EHV-1) in respiratory tract associated lymphoid tissue: implications for cellular immunity. Equine Vet. J. 26:470-473.
22. Kydd JH, Townsend HG, Hannant D. 2006. The equine immune response to equine herpesvirus-1: the virus and its vaccines. Vet. Immunol. Immunopathol. 111:15-30.
23. Kydd JH, Wattrang E, Hannant D. 2003. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares. Vet. Immunol. Immunopathol. 96:207-217. (Pubitemid 37330001)
24. Lewis MJ, Wagner B, Woof JM. 2008. The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies. Mol. Immunol. 45:818-827. (Pubitemid 47498575)
25. Lunn DP, et al. 2009. Equine herpesvirus-1 consensus statement. J. Vet. Intern. Med. 23:450-461.
26. Lunn DP, et al. 1991. Haematological changes and equine lymphocyte subpopulation kinetics during primary infection and attempted reinfection of specific pathogen free foals with EHV-1. Equine Vet. J. 23:35-40.
27. Mumford JA, et al. 1994. Abortigenic and neurological disease caused by experimental infection with equid herpesvirus-1, p. 261-275. In Nakajima H, Plowright W (ed.), Equine infectious diseases VII: proceedings of the Seventh International Conference, Tokyo. R&W Publications, Newmarket, United Kingdom.
28. O'Neill T, et al. 1999. Determination of equid herpesvirus 1-specific, CD8+, cytotoxic T lymphocyte precursor frequencies in ponies. Vet. Immunol. Immunopathol. 70:43-54. (Pubitemid 29428043)
29. Osterrieder N, et al. 2003. Establishment and use of infectious bacterial artificial chromosome (BAC) DNA clones of animal herpesviruses. Berl. Munch. Tierarztl. Wochenschr. 116:373-380. (In German.) (Pubitemid 37171923)
30. Paillot R, et al. 2005. Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1. Vaccine 23:4541-4551. (Pubitemid 40967983)
31. Paillot R, et al. 2007. Frequency and phenotype of EHV-1 specific, IFN-gamma synthesising lymphocytes in ponies: the effects of age, pregnancy and infection. Dev. Comp. Immunol. 31:202-214. (Pubitemid 44436569)
32. Paillot R, et al. 2006. Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection. Vaccine 24:1490-1500. (Pubitemid 43238223)
33. Perkins GA, Goodman LB, Dubovi EJ, Kim SG, Osterrieder N. 2008. Detection of equine herpesvirus-1 in nasal swabs of horses by quantitative real-time PCR. J. Vet. Intern. Med. 22:1234-1238.
34. Sheoran AS, Lunn DP, Holmes MA. 1998. Monoclonal antibodies to subclass-specific antigenic determinants on equine immunoglobulin gamma chains and their characterization. Vet. Immunol. Immunopathol. 62:153-165. (Pubitemid 28222409)
35. Soboll Hussey G, et al. 2011. Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant. Vet. Res. 42:23.
36. Thomson GR, Mumford JA, Campbell J, Griffiths L, Clapham P. 1976. Serological detection of equid herpesvirus 1 infections of the respiratory tract. Equine Vet. J. 8:58-65.
37. Tischer BK, von Einem J, Kaufer B, Osterrieder N. 2006. Two-step red-mediated recombination for versatile high-efficiency markerlessDNA manipulation in Escherichia coli. Biotechniques 40:191-197. (Pubitemid 46542640)
38. van Maanen C. 2002. Equine herpesvirus 1 and 4 infections: an update. Vet. Q. 24:58-78. (Pubitemid 34679835)
39. Wagner B. 2006. Immunoglobulins and immunoglobulin genes of the horse. Dev. Comp. Immunol. 30:155-164. (Pubitemid 41405792)
40. Wagner B, Burton A, Ainsworth D. 2010. Interferon-gamma, interleukin-4 and interleukin-10 production by T helper cells reveals intact Th1 and regulatory TR1 cell activation and a delay of the Th2 cell response in equine neonates and foals. Vet. Res. 41:47.
41. Wagner B, Freer H. 2009. Development of a bead-based multiplex assay for simultaneous quantification of cytokines in horses. Vet. Immunol. Immunopathol. 127:242-248.
42. Wagner B, Radbruch A, Rohwer J, Leibold W. 2003. Monoclonal antiequine IgE antibodies with specificity for different epitopes on the immunoglobulin heavy chain of native IgE. Vet. Immunol. Immunopathol. 92:45-60. (Pubitemid 36298682)
43. Wagner B, Wimer C, Freer H, Osterrieder N, Erb HN. 2011. Infection of peripheral blood mononuclear cells with neuropathogenic equine herpesvirus type-1 strain Ab4 reveals intact interferon-alpha induction and induces suppression of anti-inflammatory interleukin-10 responses in comparison to other viral strains. Vet. Immunol. Immunopathol. 143:116-124.
44. Wang L, Raidal SL, Pizzirani A, Wilcox GE. 2007. Detection of respiratory herpesviruses in foals and adult horses determined by nested multiplex PCR. Vet. Microbiol. 121:18-28.